Symbols / PPCB $0.12 +1.68% Propanc Biopharma, Inc.

Healthcare • Biotechnology • Australia • NCM
PPCB Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 2.51M Enterprise Value 2.82M Income -67.00M Sales Book/sh 0.78 Cash/sh 0.04
Dividend Yield Payout 0.00% Employees 1 IPO P/E 0.00 Forward P/E
PEG P/S P/B 0.15 P/C EV/EBITDA -0.04 EV/Sales
Quick Ratio 0.16 Current Ratio 2.13 Debt/Eq 5.67 LT Debt/Eq EPS (ttm) 52.11 EPS next Y
EPS Growth Revenue Growth Earnings ROA -5.36% ROE -18.12% ROIC
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 21.86M Shs Float 10.83M Short Float 0.96%
Short Ratio 0.07 Short Interest 52W High 10.81 52W Low 0.10 Beta 3.52 Avg Volume 4.13M
Volume 1.95M Target Price Recom None Prev Close $0.11 Price $0.12 Change 1.68%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$11.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest PPCB news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category